Interventions to prevent pregnancy complications have been largely unsuccessful. We
suggest this is because the foundation for a healthy pregnancy is laid prior to the …

Background. Placenta accreta spectrum (PAS) is a condition of abnormal placental invasion
encompassing placenta accreta, increta, and percreta and is a major cause of severe …

Prenatal testing for chromosomal abnormalities is designed to provide an accurate
assessment of a patient's risk of carrying a fetus with a chromosomal disorder. A wide variety …

Intrauterine growth restriction (IUGR) is associated with perinatal morbidity and mortality.
IUGR is defined as fetus that fails to achieve his growth potential. Antenatal small for …

Objective Direct chromosome preparations of chorionic villus samples (CVS) and cell‐free
DNA (cfDNA) testing both involve analysis of the trophoblastic cell lineage. The aim of this …

Preeclampsia is characterized by hypertension and proteinuria twenty weeks into
pregnancy. Failure of uterine spiral artery remodeling contributes to preeclampsia's …

Objective To examine the relationship between maternal characteristics, serum biomarkers
and preterm birth (PTB) by spontaneous and medically indicated subtypes. Design …

The objective was to determine the strength of relationship between maternal free beta
human chorionic gonadotropin (β-hCG) concentrations and rates of adverse pregnancy …

Placenta accreta spectrum (PAS) disorders refers to a heterogeneous group of anomalies
distinguished by abnormal adhesion or invasion of chorionic villi through the myometrium …

Prenatal testing for chromosomal abnormalities is designed to provide an accurate
assessment of a patient's risk of carrying a fetus with a chromosomal disorder. A wide variety …